Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:ACKNOWLEDGEMENTS TO REVIEWERS (2014-2015)
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO REVIEWERS (2014-2015), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2015; 9 (2) . https://dx.doi.org/10.2174/187221480902151221161536
DOI https://dx.doi.org/10.2174/187221480902151221161536 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
17
Related Articles
-
Individual Differences in the Neurobiology of Social Stress: Implications for Depression-Cardiovascular Disease Comorbidity
Current Neuropharmacology Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design The Posttranslational Phase of Gene Expression: New Possibilities in Molecular Diagnosis
Current Molecular Medicine Polymeric Nanocarriers for the Oral Delivery of Bioactives
Current Drug Therapy Good at Heart: Preserving Cardiac Metabolism during aging
Current Diabetes Reviews Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Vascular effects of flavonoids
Current Medicinal Chemistry Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimers Disease Mechanisms
Current Alzheimer Research Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke
Current Pharmaceutical Design Demonstration of the Efficacy of Statins in Resolution of Plaque Inflammation by Serial FDG Imaging
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Genes, Environment, and Interactions in Prevention of Type 2 Diabetes: A Focus on Physical Activity and Lifestyle Changes
Current Molecular Medicine Diabetes Mellitus-Cell Transplantation and Gene Therapy Approaches.
Current Molecular Medicine Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy
Current Vascular Pharmacology The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Dense Gas Technology and Cyclodextrins: State of the Art and Potential
Current Organic Chemistry Nutritional Modulation of Terminal End Buds: Its Relevance to Breast Cancer Prevention
Current Cancer Drug Targets Current Immunotherapies for Renal Cell Carcinoma
Current Molecular Pharmacology Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Further Vitamin D Analogs
Current Vascular Pharmacology